{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:32:29Z","timestamp":1776508349667,"version":"3.51.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Rare and Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan","award":["21FC1010"],"award-info":[{"award-number":["21FC1010"]}]},{"name":"Rare and Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan","award":["21FC1010"],"award-info":[{"award-number":["21FC1010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-024-01680-8","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:02:06Z","timestamp":1723420926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Generation of a mouse model of thyroid storm and preliminary investigation of the therapeutic effects of ghrelin"],"prefix":"10.1186","volume":"24","author":[{"given":"Chiaki","family":"Kurimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Akamizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Iwakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ariyasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taka-Aki","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"1680_CR1","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1089\/thy.2011.0334","volume":"22","author":"T Akamizu","year":"2012","unstructured":"Akamizu T, Satoh T, Isozaki O, et al. Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid. 2012;22:661\u201379. https:\/\/doi.org\/10.1089\/thy.2011.0334.","journal-title":"Thyroid"},{"key":"1680_CR2","unstructured":"Pokhrel B, Aiman W, Bhusal K, Thyroid S. StatPearls [Internet];2022 Oct 6. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448095\/?report=printable [Last accessed: 1\/31\/2024]."},{"issue":"6","key":"1680_CR3","first-page":"5","volume":"24","author":"SW Spaulding","year":"2012","unstructured":"Spaulding SW. A large nationwide survey of patients hospitalized with thyroid storm has been used to develop a different approach to characterizing the disease. Clin Thyroidol. 2012;24(6):5\u20137.","journal-title":"Clin Thyroidol"},{"issue":"1","key":"1680_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/MMBR.05015-11","volume":"76","author":"JR Tisoncik","year":"2012","unstructured":"Tisoncik JR, Korth MJ, Simmons CP, et al. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012;76(1):16\u201332. https:\/\/doi.org\/10.1128\/MMBR.05015-11.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"2","key":"1680_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1210\/jcem.84.2.5436","volume":"84","author":"A Siddiqi","year":"1999","unstructured":"Siddiqi A, Monson JP, Wood DF, et al. Serum cytokines in thyrotoxicosis. J Clin Endocrinol Metab. 1999;84(2):435\u20139. https:\/\/doi.org\/10.1210\/jcem.84.2.5436.","journal-title":"J Clin Endocrinol Metab"},{"key":"1680_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1530\/eje.0.1430197","volume":"143","author":"M Salvi","year":"2000","unstructured":"Salvi M, Pedrazzoni M, Girasole G, et al. Serum concentrations of proinflammatory cytokines in Graves\u2019 disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol. 2000;143:197\u2013202. https:\/\/doi.org\/10.1530\/eje.0.1430197.","journal-title":"Eur J Endocrinol"},{"key":"1680_CR7","doi-asserted-by":"publisher","first-page":"44822","DOI":"10.1038\/srep44822","volume":"7","author":"L Zhou","year":"2017","unstructured":"Zhou L, Liu Z, Wang Z, et al. Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo. Sci Rep. 2017;7:44822. https:\/\/doi.org\/10.1038\/srep44822.","journal-title":"Sci Rep"},{"key":"1680_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-9255-4-22","volume":"4","author":"H Huang","year":"2007","unstructured":"Huang H, Liu T, Rose JL, et al. Sensitivity of mice to lipopolysaccharide is increased by a high saturated fat and cholesterol diet. J Inflamm (Lond). 2007;4:22. https:\/\/doi.org\/10.1186\/1476-9255-4-22.","journal-title":"J Inflamm (Lond)"},{"key":"1680_CR9","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fimmu.2020.00724","volume":"11","author":"J Yang","year":"2020","unstructured":"Yang J, Wise L, Fukuchi KI. TLR4 cross-talk with NLRP3 inflammasome and Complement Signaling pathways in Alzheimer\u2019s Disease. Front Immunol. 2020;11:724. https:\/\/doi.org\/10.3389\/fimmu.2020.00724.","journal-title":"Front Immunol"},{"key":"1680_CR10","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1210\/en.2003-0427","volume":"144","author":"Y Hataya","year":"2003","unstructured":"Hataya Y, Akamizu T, Hosoda H, et al. Alterations of plasma ghrelin levels in rats with lipopolysaccharide-induced wasting syndrome and effects of ghrelin treatment on the syndrome. Endocrinology. 2003;144:5365\u201371. https:\/\/doi.org\/10.1210\/en.2003-0427.","journal-title":"Endocrinology"},{"issue":"3","key":"1680_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1210\/er.2002-0029","volume":"25","author":"AJ Van der Lely","year":"2004","unstructured":"Van der Lely AJ, Tsch\u00f6p M, Heiman ML, et al. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 2004;25(3):426\u201357. https:\/\/doi.org\/10.1210\/er.2002-0029.","journal-title":"Endocr Rev"},{"key":"1680_CR12","doi-asserted-by":"publisher","first-page":"8369","DOI":"10.4049\/jimmunol.180.12.8369","volume":"180","author":"A Chorny","year":"2008","unstructured":"Chorny A, Anderson P, Gonzalez-Rey E, et al. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J Immunol. 2008;180:8369\u201377. https:\/\/doi.org\/10.4049\/jimmunol.180.12.8369.","journal-title":"J Immunol"},{"key":"1680_CR13","unstructured":"Edition AVMA, Guidelines for the Euthanasia of Animals. : 2020 Edition. https:\/\/www.avma.org\/sites\/default\/files\/2020-02\/Guidelines-on-Euthanasia-2020.pdf\u3000[Last accessed: 5\/7\/2024]."},{"key":"1680_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/1756-0500-7-233","volume":"7","author":"B Shrum","year":"2014","unstructured":"Shrum B, Anantha RV, Xu SX, et al. A robust scoring system to evaluate sepsis severity in an animal model. BMC Res Notes. 2014;7:233. https:\/\/doi.org\/10.1186\/1756-0500-7-233.","journal-title":"BMC Res Notes"},{"key":"1680_CR15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s11745-013-3769-3","volume":"48","author":"A Chabowski","year":"2013","unstructured":"Chabowski A, Zendzian-Piotrowska M, Mik\u0142osz A, et al. Fiber specific changes in sphingolipid metabolism in skeletal muscles of hyperthyroid rats. Lipids. 2013;48:697\u2013704. https:\/\/doi.org\/10.1007\/s11745-013-3769-3.","journal-title":"Lipids"},{"key":"1680_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1042\/cs0880533","volume":"88","author":"G Eisenhofer","year":"1995","unstructured":"Eisenhofer G, Friberg P, Pacak K, et al. Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism? Clin Sci. 1995;88:533\u201342. https:\/\/doi.org\/10.1042\/cs0880533.","journal-title":"Clin Sci"},{"issue":"1","key":"1680_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1530\/acta.0.1100075","volume":"110","author":"D Ratge","year":"1985","unstructured":"Ratge D, Hansel-Bessey S, et al. Altered plasma catecholamines and numbers of alpha- and beta-adrenergic receptors in platelets and leucocytes in hyperthyroid patients normalized under antithyroid treatment. Acta Endocrinol. 1985;110(1):75\u201382. https:\/\/doi.org\/10.1530\/acta.0.1100075.","journal-title":"Acta Endocrinol"},{"issue":"12","key":"1680_CR18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1507\/endocrj.EJ16-0336","volume":"63","author":"T Satoh","year":"2016","unstructured":"Satoh T, Isozaki O, Suzuki A, et al. 2016 guidelines for the management of thyroid storm from the Japan Thyroid Association and Japan Endocrine Society (First Edition). Endocr J. 2016;63(12):1025\u201364. https:\/\/doi.org\/10.1507\/endocrj.EJ16-0336.","journal-title":"Endocr J"},{"key":"1680_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0889-8529(18)30165-8","volume":"22","author":"HB Burch","year":"1993","unstructured":"Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22:263\u201377.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1680_CR20","doi-asserted-by":"publisher","unstructured":"Silva JE, Bianco SDC. Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid 2008; Feb 18(2):157\u201365; https:\/\/doi.org\/10.1089\/thy.2007.0252","DOI":"10.1089\/thy.2007.0252"},{"key":"1680_CR21","doi-asserted-by":"publisher","first-page":"11498","DOI":"10.1038\/ncomms11498","volume":"7","author":"S Honda","year":"2016","unstructured":"Honda S, Sato K, Totsuka N, et al. Marginal zone B cells exacerbate endotoxic shock via interleukin-6 secretion induced by Fca\/mR-coupled TLR4 signalling. Nat Commun. 2016;7:11498. https:\/\/doi.org\/10.1038\/ncomms11498.","journal-title":"Nat Commun"},{"issue":"6","key":"1680_CR22","doi-asserted-by":"publisher","first-page":"e1007622","DOI":"10.1371\/journal.pcbi.1007622","volume":"16","author":"AK Smith","year":"2020","unstructured":"Smith AK, Ropella GEP, McGill MR, et al. Contrasting model mechanisms of alanine aminotransferase (ALT) release from damaged and necrotic hepatocytes as an example of general biomarker mechanisms. PLoS Comput Biol. 2020;16(6):e1007622. https:\/\/doi.org\/10.1371\/journal.pcbi.1007622.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"1680_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1172\/JCI21134","volume":"114","author":"VD Dixit","year":"2004","unstructured":"Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 2004;114(1):57\u201366. https:\/\/doi.org\/10.1172\/JCI21134.","journal-title":"J Clin Invest"},{"issue":"3","key":"1680_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/01.sla.0000251614.42290.ed","volume":"245","author":"R Wu","year":"2007","unstructured":"Wu R, Dong W, Cui X, et al. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg. 2007;245(3):480\u20136. https:\/\/doi.org\/10.1097\/01.sla.0000251614.42290.ed.","journal-title":"Ann Surg"},{"issue":"2\u20133","key":"1680_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/s0014-2999(03)01972-1","volume":"473","author":"L Chang","year":"2003","unstructured":"Chang L, Zhao J, Yang J, et al. Therapeutic effects of ghrelin on endotoxic shock in rats. Eur J Pharmacol. 2003;473(2\u20133):171\u20136. https:\/\/doi.org\/10.1016\/s0014-2999(03)01972-1.","journal-title":"Eur J Pharmacol"},{"key":"1680_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00408-015-9685-y","volume":"193","author":"N Matsumoto","year":"2015","unstructured":"Matsumoto N, Miki K, Tsubouchi H, et al. Ghrelin administration for chronic respiratory failure: a randomized dose-comparison trial. Lung. 2015;193:239\u201347. https:\/\/doi.org\/10.1007\/s00408-015-9685-y.","journal-title":"Lung"},{"key":"1680_CR27","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1161\/01.CIR.0000149746.62908.BB","volume":"110","author":"N Nagaya","year":"2004","unstructured":"Nagaya N, Moriya J, Yasumura Y, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 2004;110:3674\u20139. https:\/\/doi.org\/10.1161\/01.CIR.0000149746.62908.BB.","journal-title":"Circulation"},{"issue":"3","key":"1680_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1358\/dot.2022.58.3.3381585","volume":"58","author":"K Nishie","year":"2022","unstructured":"Nishie K, Sato S, Hanaoka M. Anamorelin for cancer cachexia. Drugs Today (Barc). Mar; 2022;58(3):97\u2013104. https:\/\/doi.org\/10.1358\/dot.2022.58.3.3381585.","journal-title":"Drugs Today (Barc)"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01680-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-024-01680-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01680-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:03:18Z","timestamp":1723420998000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-024-01680-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1680"],"URL":"https:\/\/doi.org\/10.1186\/s12902-024-01680-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4346300\/v1","asserted-by":"object"}]},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"assertion":[{"value":"30 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We obtained ethical approval for use of an opt-out method for this study, and none of the subjects declined participation. Therefore, informed consent was not required. This study protocol was approved by the Wakayama Medical University Institutional Ethical Review Board (No.3714). Animal care and all experimental procedures were performed in accordance with the Wakayama Medical University Guidelines for Animal Experiments, with the approval of the Institutional Animal Care and Use Committee (No. 819).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}